|
|
Volumn 1, Issue 1, 2006, Pages 25-33
|
|
The safety of medications for the treatment of bipolar disorder during pregnancy and the puerperium.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
NEUROLEPTIC AGENT;
TERATOGENIC AGENT;
TRANQUILIZER;
BIPOLAR DISORDER;
CLINICAL TRIAL;
DRUG EFFECT;
FEMALE;
HUMAN;
NEWBORN;
PREGNANCY;
PREGNANCY COMPLICATION;
PSYCHOLOGICAL ASPECT;
PUERPERIUM;
REVIEW;
ANTICONVULSANTS;
ANTIDEPRESSIVE AGENTS;
ANTIMANIC AGENTS;
ANTIPSYCHOTIC AGENTS;
BIPOLAR DISORDER;
CLINICAL TRIALS AS TOPIC;
FEMALE;
HUMANS;
INFANT, NEWBORN;
POSTPARTUM PERIOD;
PREGNANCY;
PREGNANCY COMPLICATIONS;
TERATOGENS;
|
|
EID: 50649121127
PISSN: 15748863
EISSN: None
Source Type: Journal
DOI: 10.2174/157488606775252692 Document Type: Review |
|
Times cited : (18)
|
|
References (104)
|
